SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Intensity Therapeutics, Inc. (INTS) News

Follow Intensity Therapeutics, Inc. (INTS) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 5 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol INTS Asset equity Sector Markets 90 days 4 Last 2.575 Updated Nov 05, 2026, 04:14 PM UTC Open live news feed Open INTS chart & news
M Intensity Therapeutics Reports Quarterly Results Intensity Therapeutics reported results for the quarter ended September 30. No financial figures are provided. EQUITY | Nov 05, 2026, 04:14 PM UTC M Intensity Therapeutics Q3 Net Loss Widens on Higher R&D Costs EQUITY | Nov 05, 2026, 01:03 PM UTC M Intensity Therapeutics Reports Wider Third-Quarter Net Loss Intensity Therapeutics said higher research and development spending increased its third-quarter net loss year over year, citing costs for the INVINCIBLE-3 trial, a new INT230-6 manufacturing batch and salary-related exp EQUITY | Nov 05, 2026, 12:47 PM UTC L INTS - Intensity Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference INTS - Intensity Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference EQUITY | Sep 08, 2026, 12:01 PM UTC L INTS INTS - Intensity Therapeutics to Announce Second Quarter 2026 Financial Results on August 11, 2026 INTS INTS - Intensity Therapeutics to Announce Second Quarter 2026 Financial Results on August 11, 2026 EARNINGS | Aug 04, 2026, 12:01 PM UTC